PURPOSE: Infection with human papillomaviruses (HPV) is associated with the development of cervical cancer, but whether HPVs have a role in colorectal cancer remains controversial. EXPERIMENTAL DESIGNS: To determine the relationship between HPV and colorectal cancer, we did a retrospective, controlled study using tumor and tumor-adjacent colorectal tissues dissected from patients with colorectal cancer, as well as colorectal tissues from control individuals with no cancer. The samples were processed in a blinded fashion for nested PCR and in situ PCR detection of HPV DNAs. The PCR products were gel-purified and sequenced for HPV genotyping. RESULTS: We found that colorectal tissues from 28 of 55 (51%) patients with colorectal cancer were positive for HPV DNA. Colorectal tissues from all 10 control individuals were negative for HPV DNA (P = 0.0034). Of the 107 usable (GAPDH(+)) samples collected as paired colorectal tissues (tumor and tumor-adjacent tissues) from the patients, 38 (36%) had HPV16 (n = 31), HPV18 (n = 5), or HPV45 (n = 2), with HPV DNA in both tumor and tumor-adjacent tissues of 10 paired samples, 13 in only the tumor, and 5 in only tumor-adjacent tissues. In situ PCR detection of the tumor tissues confirmed the presence of HPV DNA in tumor cells. CONCLUSION: Our results suggest that colorectal HPV infection is common in patients with colorectal cancer, albeit at a low DNA copy number, with HPV16 being the most prevalent type. HPV infection may play a role in colorectal carcinogenesis.
PURPOSE: Infection with human papillomaviruses (HPV) is associated with the development of cervical cancer, but whether HPVs have a role in colorectal cancer remains controversial. EXPERIMENTAL DESIGNS: To determine the relationship between HPV and colorectal cancer, we did a retrospective, controlled study using tumor and tumor-adjacent colorectal tissues dissected from patients with colorectal cancer, as well as colorectal tissues from control individuals with no cancer. The samples were processed in a blinded fashion for nested PCR and in situ PCR detection of HPV DNAs. The PCR products were gel-purified and sequenced for HPV genotyping. RESULTS: We found that colorectal tissues from 28 of 55 (51%) patients with colorectal cancer were positive for HPV DNA. Colorectal tissues from all 10 control individuals were negative for HPV DNA (P = 0.0034). Of the 107 usable (GAPDH(+)) samples collected as paired colorectal tissues (tumor and tumor-adjacent tissues) from the patients, 38 (36%) had HPV16 (n = 31), HPV18 (n = 5), or HPV45 (n = 2), with HPV DNA in both tumor and tumor-adjacent tissues of 10 paired samples, 13 in only the tumor, and 5 in only tumor-adjacent tissues. In situ PCR detection of the tumor tissues confirmed the presence of HPV DNA in tumor cells. CONCLUSION: Our results suggest that colorectal HPV infection is common in patients with colorectal cancer, albeit at a low DNA copy number, with HPV16 being the most prevalent type. HPV infection may play a role in colorectal carcinogenesis.
Authors: P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple Journal: J Clin Microbiol Date: 2000-01 Impact factor: 5.948
Authors: R Klaes; S M Woerner; R Ridder; N Wentzensen; M Duerst; A Schneider; B Lotz; P Melsheimer; M von Knebel Doeberitz Journal: Cancer Res Date: 1999-12-15 Impact factor: 12.701
Authors: M L Gillison; W M Koch; R B Capone; M Spafford; W H Westra; L Wu; M L Zahurak; R W Daniel; M Viglione; D E Symer; K V Shah; D Sidransky Journal: J Natl Cancer Inst Date: 2000-05-03 Impact factor: 13.506
Authors: H D Strickler; M H Schiffman; K V Shah; C S Rabkin; J T Schiller; S Wacholder; B Clayman; R P Viscidi Journal: Eur J Cancer Prev Date: 1998-08 Impact factor: 2.497
Authors: Angelika Iftner; Stefanie J Klug; Claus Garbe; Andreas Blum; Alice Stancu; Sharon P Wilczynski; Thomas Iftner Journal: Cancer Res Date: 2003-11-01 Impact factor: 12.701
Authors: Ioannis N Mammas; George Sourvinos; Apostolos Zaravinos; Demetrios A Spandidos Journal: Pathol Oncol Res Date: 2010-07-18 Impact factor: 3.201
Authors: Rhonda C Kines; Rebecca J Cerio; Jeffrey N Roberts; Cynthia D Thompson; Elisabet de Los Pinos; Douglas R Lowy; John T Schiller Journal: Int J Cancer Date: 2015-10-27 Impact factor: 7.396
Authors: Andrea N Burnett-Hartman; Polly A Newcomb; Margaret T Mandelson; Denise A Galloway; Margaret M Madeleine; Michelle A Wurscher; Joseph J Carter; Karen W Makar; John D Potter; Stephen M Schwartz Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-08-04 Impact factor: 4.254
Authors: Michele C Gornick; Xavier Castellsague; Gloria Sanchez; Thomas J Giordano; Michelle Vinco; Joel K Greenson; Gabriel Capella; Leon Raskin; Gad Rennert; Stephen B Gruber; Victor Moreno Journal: Cancer Causes Control Date: 2010-01-20 Impact factor: 2.506
Authors: Vanessa Deschoolmeester; Veerle Van Marck; Marc Baay; Christine Weyn; Peter Vermeulen; Eric Van Marck; Filip Lardon; Veronique Fontaine; Jan B Vermorken Journal: BMC Cancer Date: 2010-03-26 Impact factor: 4.430